Noriyasu Haginoya - Concepedia

Author

Noriyasu Haginoya

Daiichi-Sankyo (Japan)

Also Known As

N. HAGINOYA, N. Haginoya, Noriyasu Haginoya

Publications

675

Citations

H-Index

Concepts

All Affiliations

Daiichi-Sankyo (Japan)Daiichi University of Pharmacy Daiichi Sankyo (Germany)Hokkaido University The University of Tokyo

About

Noriyasu Haginoya is an author at Daiichi-Sankyo (Japan) specializing in natural sciences, pharmacology, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	13	13	456
2	Medicine	12	12	410
3	Biochemistry	10	10	363
4	Biomolecular Engineering	2	2	73
5	Engineering	1	1	50

Noriyasu Haginoya

Publications

664

Citations

H-Index

Page 1

	Year	Citations
Synthesis and Conformational Analysis of a Non-Amidine Factor Xa Inhibitor That Incorporates 5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-<i>c</i>]pyridine as S4 Binding Element Noriyasu Haginoya, Syozo Kobayashi, Satoshi Komoriya, Journal of Medicinal Chemistry Pharmaceutical ScienceBioorganic ChemistryX-ray Crystal AnalysisPharmacotherapyHeterocycle Chemistry	2004	70
Nucleosides and Nucleotides. 160. Synthesis of Oligodeoxyribonucleotides Containing 5-(<i>N</i>-Aminoalkyl)carbamoyl-2‘-deoxyuridines by a New Postsynthetic Modification Method and Their Thermal Stability and Nuclease-Resistance Properties Noriyasu Haginoya, Akira Ono, Yukari Nomura, Bioconjugate Chemistry Bioorganic ChemistryDuplex FormationEngineeringMolecular BiologyOrganic Chemistry	1997	50
DS-1205b, a novel selective inhibitor of AXL kinase, blocks resistance to EGFR-tyrosine kinase inhibitors in a non-small cell lung cancer xenograft model Takeshi Jimbo, Mana Hatanaka, Takahiro Komatsu, Oncotarget	2019	47
Discovery of N-[(1R,2S,5S)-2-{[(5-chloroindol-2-yl)carbonyl]amino}-5-(dimethylcarbamoyl)cyclohexyl]-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamide hydrochloride: A novel, potent and orally active direct inhibitor of factor Xa Tsutomu Nagata, Toshiharu Yoshino, Noriyasu Haginoya, Bioorganic & Medicinal Chemistry Medicinal ChemistryBiochemistryMedicineNatural SciencesRational Drug Design	2008	42
Design, synthesis, and SAR of cis-1,2-diaminocyclohexane derivatives as potent factor Xa inhibitors. Part II: Exploration of 6–6 fused rings as alternative S1 moieties Kenji Yoshikawa, Shozo Kobayashi, Yumi Nakamoto, Bioorganic & Medicinal Chemistry Medicinal ChemistryNatural SciencesDrug DiscoveryDiversity-oriented SynthesisMedicine	2009	42
Design, synthesis, and biological activity of novel factor Xa inhibitors: Improving metabolic stability by S1 and S4 ligand modification Satoshi Komoriya, Shozo Kobayashi, Ken Osanai, Bioorganic & Medicinal Chemistry Biological ActivityMedicinal ChemistryMetabolic StabilityBiochemistryNatural Sciences	2005	42
Discovery of Novel Thieno[2,3-d]pyrimidin-4-yl Hydrazone-Based Cyclin-Dependent Kinase 4 Inhibitors: Synthesis, Biological Evaluation and Structure-Activity Relationships Takao Horiuchi, Yasuyuki Takeda, Noriyasu Haginoya, Chemical and Pharmaceutical Bulletin	2011	37
Nucleosides and nucleotides. 127. A novel and convenient post-synthetic modification method for the synthesis of oligodeoxyribonucleotides carrying amino linkers at the 5-position of 2′-deoxyuridine Akira Ono, Noriyasu Haginoya, Mitsugu Kiyokawa, Bioorganic & Medicinal Chemistry Letters BiosynthesisBioorganic ChemistryNucleic Acid ChemistryBiochemistryNatural Sciences	1994	33
Cycloalkanediamine derivatives as novel blood coagulation factor Xa inhibitors Tsutomu Nagata, Toshiharu Yoshino, Noriyasu Haginoya, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineCycloalkanediamine DerivativesPharmacotherapyAnti-cancer Agent	2007	33
Design, synthesis, and biological activity of non-amidine factor Xa inhibitors containing pyridine N-oxide and 2-carbamoylthiazole units Noriyasu Haginoya, Syozo Kobayashi, Satoshi Komoriya, Bioorganic & Medicinal Chemistry Biological ActivityMedicinal ChemistryBiochemistryMedicineNatural Sciences	2004	31

Page 1